Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 7/2016

01-07-2016 | Original Article

Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls

Authors: Ralph Buchert, Andreas Kluge, Livia Tossici-Bolt, John Dickson, Marcus Bronzel, Catharina Lange, Susanne Asenbaum, Jan Booij, L. Özlem Atay Kapucu, Claus Svarer, Pierre-Malick Koulibaly, Flavio Nobili, Marco Pagani, Osama Sabri, Terez Sera, Klaus Tatsch, Thierry Vander Borght, Koen Van Laere, Andrea Varrone, Hidehiro Iida

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 7/2016

Login to get access

Abstract

Purpose

Quantitative estimates of dopamine transporter availability, determined with [123I]FP-CIT SPECT, depend on the SPECT equipment, including both hardware and (reconstruction) software, which limits their use in multicentre research and clinical routine. This study tested a dedicated reconstruction algorithm for its ability to reduce camera-specific intersubject variability in [123I]FP-CIT SPECT. The secondary aim was to evaluate binding in whole brain (excluding striatum) as a reference for quantitative analysis.

Methods

Of 73 healthy subjects from the European Normal Control Database of [123I]FP-CIT recruited at six centres, 70 aged between 20 and 82 years were included. SPECT images were reconstructed using the QSPECT software package which provides fully automated detection of the outer contour of the head, camera-specific correction for scatter and septal penetration by transmission-dependent convolution subtraction, iterative OSEM reconstruction including attenuation correction, and camera-specific “to kBq/ml” calibration. LINK and HERMES reconstruction were used for head-to-head comparison. The specific striatal [123I]FP-CIT binding ratio (SBR) was computed using the Southampton method with binding in the whole brain, occipital cortex or cerebellum as the reference. The correlation between SBR and age was used as the primary quality measure.

Results

The fraction of SBR variability explained by age was highest (1) with QSPECT, independently of the reference region, and (2) with whole brain as the reference, independently of the reconstruction algorithm.

Conclusion

QSPECT reconstruction appears to be useful for reduction of camera-specific intersubject variability of [123I]FP-CIT SPECT in multisite and single-site multicamera settings. Whole brain excluding striatal binding as the reference provides more stable quantitative estimates than occipital or cerebellar binding.
Literature
1.
go back to reference Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266–72.CrossRefPubMed Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266–72.CrossRefPubMed
2.
go back to reference Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62:133–40.CrossRefPubMedPubMedCentral Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62:133–40.CrossRefPubMedPubMedCentral
4.
go back to reference Van Laere K, Everaert L, Annemans L, Gonce M, Vandenberghe W, Vander Borght T. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging. 2008;35:1367–76. doi:10.1007/s00259-008-0777-2.CrossRefPubMed Van Laere K, Everaert L, Annemans L, Gonce M, Vandenberghe W, Vander Borght T. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging. 2008;35:1367–76. doi:10.​1007/​s00259-008-0777-2.CrossRefPubMed
5.
go back to reference Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73:134–40.CrossRefPubMedPubMedCentral Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73:134–40.CrossRefPubMedPubMedCentral
6.
go back to reference Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson’s disease. J Nucl Med. 1998;39:1879–84.PubMed Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson’s disease. J Nucl Med. 1998;39:1879–84.PubMed
7.
go back to reference Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443–50. doi:10.1007/s00259-009-1267-x.CrossRefPubMed Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443–50. doi:10.​1007/​s00259-009-1267-x.CrossRefPubMed
8.
go back to reference Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med. 2005;46:1109–18.PubMed Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med. 2005;46:1109–18.PubMed
9.
go back to reference Soderlund TA, Dickson JC, Prvulovich E, Ben-Haim S, Kemp P, Booij J, et al. Value of semiquantitative analysis for clinical reporting of 123I-2-beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med. 2013;54:714–22. doi:10.2967/jnumed.112.110106.CrossRefPubMed Soderlund TA, Dickson JC, Prvulovich E, Ben-Haim S, Kemp P, Booij J, et al. Value of semiquantitative analysis for clinical reporting of 123I-2-beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med. 2013;54:714–22. doi:10.​2967/​jnumed.​112.​110106.CrossRefPubMed
10.
go back to reference Tatsch K, Poepperl G. Quantitative approaches to dopaminergic brain imaging. Q J Nucl Med Mol Imaging. 2012;56:27–38.PubMed Tatsch K, Poepperl G. Quantitative approaches to dopaminergic brain imaging. Q J Nucl Med Mol Imaging. 2012;56:27–38.PubMed
11.
go back to reference Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33:1491–9. doi:10.1007/s00259-006-0155-x.CrossRefPubMed Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33:1491–9. doi:10.​1007/​s00259-006-0155-x.CrossRefPubMed
13.
14.
go back to reference Graham LS, Fahey FH, Madsen MT, van Aswegen A, Yester MV. Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee. Med Phys. 1995;22:401–9.CrossRefPubMed Graham LS, Fahey FH, Madsen MT, van Aswegen A, Yester MV. Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee. Med Phys. 1995;22:401–9.CrossRefPubMed
15.
go back to reference Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara MC, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011;38:1529–40. doi:10.1007/s00259-011-1801-5.CrossRefPubMed Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara MC, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011;38:1529–40. doi:10.​1007/​s00259-011-1801-5.CrossRefPubMed
16.
go back to reference McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13. doi:10.1016/S1474-4422(07)70057-1.CrossRefPubMed McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13. doi:10.​1016/​S1474-4422(07)70057-1.CrossRefPubMed
17.
go back to reference Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40:213–27. doi:10.1007/s00259-012-2276-8.CrossRefPubMed Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40:213–27. doi:10.​1007/​s00259-012-2276-8.CrossRefPubMed
18.
go back to reference Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 2013;40:565–73. doi:10.1007/s00259-012-2304-8.CrossRefPubMed Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 2013;40:565–73. doi:10.​1007/​s00259-012-2304-8.CrossRefPubMed
19.
go back to reference Iida H, Eberl S. Quantitative assessment of regional myocardial blood flow with thallium-201 and SPECT. J Nucl Cardiol. 1998;5:313–31.CrossRefPubMed Iida H, Eberl S. Quantitative assessment of regional myocardial blood flow with thallium-201 and SPECT. J Nucl Cardiol. 1998;5:313–31.CrossRefPubMed
20.
go back to reference Iida H, Narita Y, Kado H, Kashikura A, Sugawara S, Shoji Y, et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med. 1998;39:181–9.PubMed Iida H, Narita Y, Kado H, Kashikura A, Sugawara S, Shoji Y, et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med. 1998;39:181–9.PubMed
21.
go back to reference Kim K, Watabe H, Shidahara M, Ishida Y, Iida H. SPECT collimator dependency of scatter and validation of transmission-dependent scatter compensation methodologies. IEEE Trans Nucl Sci. 2001;48:689–96.CrossRef Kim K, Watabe H, Shidahara M, Ishida Y, Iida H. SPECT collimator dependency of scatter and validation of transmission-dependent scatter compensation methodologies. IEEE Trans Nucl Sci. 2001;48:689–96.CrossRef
22.
go back to reference Iida H, Nakagawara J, Hayashida K, Fukushima K, Watabe H, Koshino K, et al. Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine. J Nucl Med. 2010;51:1624–31. doi:10.2967/jnumed.110.078352.CrossRefPubMed Iida H, Nakagawara J, Hayashida K, Fukushima K, Watabe H, Koshino K, et al. Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine. J Nucl Med. 2010;51:1624–31. doi:10.​2967/​jnumed.​110.​078352.CrossRefPubMed
23.
go back to reference Yoneda H, Shirao S, Koizumi H, Oka F, Ishihara H, Ichiro K, et al. Reproducibility of cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine in institutions with different γ-cameras and collimators. J Cereb Blood Flow Metab. 2012;32:1757–64. doi:10.1038/jcbfm.2012.67.CrossRefPubMedPubMedCentral Yoneda H, Shirao S, Koizumi H, Oka F, Ishihara H, Ichiro K, et al. Reproducibility of cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine in institutions with different γ-cameras and collimators. J Cereb Blood Flow Metab. 2012;32:1757–64. doi:10.​1038/​jcbfm.​2012.​67.CrossRefPubMedPubMedCentral
24.
go back to reference Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9:97–113.CrossRefPubMed Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9:97–113.CrossRefPubMed
25.
go back to reference Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med. 1993;34:2216–21.PubMed Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med. 1993;34:2216–21.PubMed
26.
go back to reference Ogawa K, Harata Y, Ichihara T, Kubo A, Hashimoto S. A practical method for position-dependent Compton-scatter correction in single photon emission CT. IEEE Trans Med Imaging. 1991;10:408–12. doi:10.1109/42.97591.CrossRefPubMed Ogawa K, Harata Y, Ichihara T, Kubo A, Hashimoto S. A practical method for position-dependent Compton-scatter correction in single photon emission CT. IEEE Trans Med Imaging. 1991;10:408–12. doi:10.​1109/​42.​97591.CrossRefPubMed
27.
go back to reference Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601–9.CrossRefPubMed Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601–9.CrossRefPubMed
28.
go back to reference Meikle SR, Hutton BF, Bailey DL. A transmission-dependent method for scatter correction in SPECT. J Nucl Med. 1994;35:360–7.PubMed Meikle SR, Hutton BF, Bailey DL. A transmission-dependent method for scatter correction in SPECT. J Nucl Med. 1994;35:360–7.PubMed
29.
go back to reference Narita Y, Eberl S, Iida H, Hutton BF, Braun M, Nakamura T, et al. Monte Carlo and experimental evaluation of accuracy and noise properties of two scatter correction methods for SPECT. Phys Med Biol. 1996;41:2481–96.CrossRefPubMed Narita Y, Eberl S, Iida H, Hutton BF, Braun M, Nakamura T, et al. Monte Carlo and experimental evaluation of accuracy and noise properties of two scatter correction methods for SPECT. Phys Med Biol. 1996;41:2481–96.CrossRefPubMed
30.
go back to reference Iida H, Shoji Y, Sugawara S, Kinoshita T, Tamura Y, Narita Y, et al. Design and experimental validation of a quantitative myocardial 201Tl SPECT system. IEEE Trans Nucl Sci. 1999;46:720–6.CrossRef Iida H, Shoji Y, Sugawara S, Kinoshita T, Tamura Y, Narita Y, et al. Design and experimental validation of a quantitative myocardial 201Tl SPECT system. IEEE Trans Nucl Sci. 1999;46:720–6.CrossRef
31.
go back to reference Fleming JS, Bolt L, Stratford JS, Kemp PM. The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol. 2004;49:N227–34.CrossRefPubMed Fleming JS, Bolt L, Stratford JS, Kemp PM. The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol. 2004;49:N227–34.CrossRefPubMed
33.
go back to reference Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell Science; 1994. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell Science; 1994.
34.
go back to reference Hall H, Halldin C, Guilloteau D, Chalon S, Emond P, Besnard J, et al. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 1999;9:108–16.CrossRefPubMed Hall H, Halldin C, Guilloteau D, Chalon S, Emond P, Besnard J, et al. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 1999;9:108–16.CrossRefPubMed
Metadata
Title
Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls
Authors
Ralph Buchert
Andreas Kluge
Livia Tossici-Bolt
John Dickson
Marcus Bronzel
Catharina Lange
Susanne Asenbaum
Jan Booij
L. Özlem Atay Kapucu
Claus Svarer
Pierre-Malick Koulibaly
Flavio Nobili
Marco Pagani
Osama Sabri
Terez Sera
Klaus Tatsch
Thierry Vander Borght
Koen Van Laere
Andrea Varrone
Hidehiro Iida
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-016-3309-5

Other articles of this Issue 7/2016

European Journal of Nuclear Medicine and Molecular Imaging 7/2016 Go to the issue